Investor Ideas #Potcasts; #Cannabis News
and Stocks on the Move; (TSX:
$WEED.TO), (TSX: $TRST.TO), (CSE:
$CRZ.C), (CSE:
$IAN.C)
Pt. Roberts, WA; Delta, BC –June 12, 2018
(Investorideas.com Newswire) www.Investorideas.com, a global news source
covering leading sectors including marijuana and hemp stocks and its “potcast’
site, www.potcasts.ca release today’s edition of
its new series, Investorideas.com potcastsCM - cannabis news and stocks to
watch plus insight from thought leaders and experts.
Listen to the podcast:
Read this in full at http://www.investorideas.com/news/2018/cannabis/06122Potcasts-TSXWEEDTRSTCSECRZIAN.asp
Today’s podcast overview/transcript:
Good afternoon and welcome to another Investorideas.com potcast –
looking at cannabis news, stocks to watch as well as insights from thought
leaders and experts. Today we are looking at announcements from Canopy Growth
Corporation (TSX: WEED and NYSE: CGC), CannTrust Holdings Inc. (TSX: TRST), CannaRoyalty Corp. (CSE: CRZ and OTCQX: CNNRF) and iAnthus
Capital Holdings, Inc. (CSE: IAN and OTCQB: ITHUF).
Canopy Growth Corporation provided updates on its medical cannabis
program and re-affirmed its strong commitment to medical cannabis, the patients
who depend on it, and the Healthcare Professionals who prescribe it.
Marking a major milestone for medical cannabis in Canada, a Phase IIb
"in-human" clinical trial application was submitted by Canopy Health
Innovations Inc. to evaluate the use of medical cannabis in the treatment of
insomnia. Having received approval to proceed with these clinical trials in the
form of a No Objection Letter (NOL) from Health Canada, Canopy Health will now
proceed with these robust clinical trials, in collaboration with a leading
Canadian research institution.
Also, as previously announced, starting in July 2018, Dr. Mark Ware
will commence his role as the Company's Chief Medical Officer. Under
his leadership the Company will continue to lead the global medical
cannabis industry forward with a focus on research, product innovation,
and stakeholder education in the numerous regions where Spectrum Cannabis
operates, including Latin America, Australia, Europe and North America.
Finally, in order to honor the company’s commitment to affordable medical
cannabis and pricing predictability for patients, Canopy Growth announced that
upon the passing of the Cannabis Act, the Company will absorb the proposed
excise tax on all Spectrum Cannabis products sold in Canada. Affordability is a
key consideration for patients. It is important today to show leadership and
reduce the price burden placed on our customers,while we work towards insurance
eligibility for medical cannabis.
On top of this, all Spectrum Cannabis dried flower products will be
priced at $8.50 per gram or less. If a registered customer is currently paying
more for a Spectrum flower product this means new savings, and if they are
paying less that price will remain the same. As always, Spectrum Cannabis
products available online through TweedMainStreet.com are eligible for our
industry-first Compassionate Pricing Program that assists those on limited
incomes afford their medicine.
CannTrust Holdings Inc., one of Canada's leading licensed producers of
medical cannabis, announced the signing of a memorandum of understanding with
Niagara College to collaborate in the development of the College's Commercial
Cannabis Production (CCP) Graduate Certificate program. The program will
strengthen CannTrust's workforce production capabilities and help fill the
growing demand for knowledgeable employees in the booming cannabis industry.
With the
launch of this new program, Niagara College will become the first Canadian
post-secondary institution to offer credits in Commercial Cannabis Production.
CannTrust will be awarding six students with scholarships as part of the
program's inauguration. The College and CannTrust are excited to be
participating in shaping the future of Canada's cannabis industry and look
forward to welcoming the program's first student intake in September 2018.
CannaRoyalty Corp., a leading
North American cannabis products and brands company, announced today that its
investee company Anandia Laboratories Inc. has signed a binding term sheet to
be acquired by Aurora Cannabis Inc. for approximately $115 million.
CannaRoyalty owns 16.5% of Anandia, and its equity stake is valued at approximately
$19 million based on the acquisition valuation, representing an almost 400%
return on investment.
This
acquisition advances CannaRoyalty's stated strategy of partnering or
rationalizing select assets that the Company has deemed non-core to its go-forward
strategy and more valuable to other parties. The proceeds will be used to fund
expansion and further acquisitions without dilution for shareholders and the
acquisition by one of Canada's largest LPs validates the significant long-term
potential that CannaRoyalty identified in the analytics, testing and genetics
verticals.
iAnthus
Capital Holdings, Inc., which owns, operates, and partners with licensed
cannabis operations throughout the United States, announced today that
Mayflower Medicinals, Inc. has signed a Host Community Agreement with the City
of Lowell, Massachusetts, to operate a Medical Marijuana Treatment Center
located at 450 Chelmsford Street. Lowell, Massachusetts.
Mayflower
intends to diligently pursue a Special Permit at the site. If granted,
the dispensary is expected to be one of only two operating dispensaries within
the Lowell city limits.
"The
Commonwealth of Massachusetts and the City of Lowell have abided by high
program standards that are firmly focused on patient care and regulatory
compliance," said John Henderson, Chief Development Officer of iAnthus.
"Mayflower is honored to have successfully completed its host community
agreement with Lowell, which adds significant value to the project by
documenting a supportive relationship between the City and the development of
the Registered Marijuana Dispensary site."
Investor ideas reminds all listeners to read
our disclaimers and disclosures on the Investorideas.com website and this
podcast is not an endorsement to buy products or services or securities.
Investors are reminded all investment involves risk and possible loss of
investment
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also available on
iTunes, Google Play Music, Stitcher and Tunein.
Potcasts is now a certified word
mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires
Big Ideas
Investorideas.com is
a meeting place for global investors, featuring news, stock directories, video,
company profiles, interviews and more in leading sectors.
Investorideas.com
cannabis/marijuana and hemp content now includes http://cannabisstocknews.blogspot.com on Blogger.com: the
Investorideas.com news and stock directory pages, a cannabis investor group on Linkedin.com
, the 420 Cannabis Investor ideas www.420cannabisinvestorideas.com, and the new AI site Global Cannabis Investing at www.Globalcannabisinvesting.com
Disclaimer/Disclosure: Investorideas.com is
a digital publisher of third party sourced news, articles and equity research
as well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investment involves risk and possible loss of investment. This site is
currently compensated for news publication and distribution, social media and
marketing, content creation and more. Contact each company directly regarding
content and press release questions. Disclosure is posted for each compensated
news release, content published /created if required but otherwise the news was
not compensated for and was published for the sole interest of our readers and
followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.
Additional info
regarding BC Residents and global Investors: Effective September 15 2008 - all
BC investors should review all OTC and Pink sheet listed companies for
adherence in new disclosure filings and filing appropriate documents with
Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations
of each country.
To sponsor this podcast or be a guest
Contact Investorideas.com
800-665-0411
No comments:
Post a Comment